Validation of next-generation sequencing-derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma
Liquid biopsy can transform oncology practice through early detection and real-time monitoring of cancer progression and response to treatment. Circulating cell-free tumor RNA offers promise as a novel and emerging alternative to circulating cell-free tumor DNA for detecting the presence and understanding the biology o...